| Name | Title | Contact Details |
|---|
Great Plains Health Alliance, Inc. is a Phillipsburg, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
We are the leading, global mid-sized contract research organization. Our team of more than 4,200 employees working across 47 countries delivers collaborative clinical development services and solutions Designed Around You®.
Hallman Group is a Kalamazoo, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Scimega Research Inc is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.